GLP-1 Eligibility in the EU: Online Consultation Guide

GLP-1 receptor agonists, such as Semaglutide (Wegovy) and Tirzepatide (Mounjaro), are prescription medications used for chronic weight management in adults. Eligibility in the EU typically requires a Body Mass Index (BMI) of 30 kg/m² or higher, or a BMI of 27 kg/m² or higher with at least one weight-related comorbidity like type 2 diabetes or high blood pressure. An EU-licensed doctor will evaluate your medical history and current health status to determine if these treatments are clinically appropriate for you.

Key Takeaways

• Eligibility for GLP-1 medications in the EU generally requires a BMI of 30+ or 27+ with a comorbidity.
• Online consultations involve a thorough review of your medical questionnaire by an EU-licensed doctor.
• A prescription is only issued if the doctor deems the treatment clinically safe and appropriate for your individual health profile.
• Hi-Doctor's service provides access to EU-licensed doctors for assessment, with a full refund if no prescription is issued.

What are GLP-1 Medications and How Do They Work?

GLP-1 receptor agonists mimic the action of a natural hormone called glucagon-like peptide-1. This hormone plays a vital role in regulating appetite and blood sugar levels. By activating GLP-1 receptors, these medications can lead to increased feelings of fullness, reduced food intake, and better glycemic control. Initially developed for type 2 diabetes, certain GLP-1 medications have been approved for weight management due to their significant impact on appetite regulation and subsequent weight loss. They are administered as injections, typically once weekly, and are intended for long-term use as part of a comprehensive weight management plan that includes diet and exercise.

Who is Eligible for GLP-1 Medications in the EU?

Eligibility criteria for GLP-1 medications for weight management are consistent across most EU countries, reflecting the guidelines set by regulatory bodies. The primary determinant is your Body Mass Index (BMI), combined with your overall health profile.

General EU Eligibility Criteria:

• BMI ≥ 30 kg/m²: Individuals with obesity, defined as a BMI of 30 or higher.
• BMI ≥ 27 kg/m² with at least one weight-related comorbidity: This includes individuals classified as overweight, who also have conditions such as type 2 diabetes, high blood pressure (hypertension), dyslipidemia (abnormal lipid levels), obstructive sleep apnea, or cardiovascular disease.

It is important to note that these are general guidelines. An EU-licensed doctor will assess your individual case, considering your full medical history, current medications, and any contraindications.

What to Expect from an Online Doctor Consultation?

An online consultation for GLP-1 eligibility begins with a comprehensive medical questionnaire. This questionnaire collects essential information about your health, including your medical history, current weight and height, lifestyle, and any existing conditions or medications.

1. Patient Completes Online Medical Questionnaire
2. EU-Licensed Doctor Reviews Information
3. Is Patient Clinically Eligible?
4. Prescription Issued (if appropriate
5. Consultation Fee Refunded
6. Patient Fills Prescription at EU Pharmacy

This process is designed to be thorough and secure, ensuring that the doctor has all necessary details to make an informed clinical decision. There are no video calls, allowing for a private and convenient experience. The doctor will review your provided information confidentially, evaluating your eligibility against established medical guidelines.

Over 50,000 patients have trusted Hi-Doctor.ai for confidential medical consultations.

Key Steps in the Online Consultation Process:

n

Step	Description	Estimated Time
1	Complete Secure Medical Questionnaire	5-10 minutes
2	Doctor Reviews Your Case	Typically under 24 hours
3	Clinical Decision Made	Part of the review process
4	Prescription Issued (if appropriate)	Within 24 hours of review
5	Collect Medication from Pharmacy	Varies by pharmacy location

The doctor's assessment focuses on patient safety and clinical appropriateness. If a prescription for a GLP-1 medication is deemed suitable, it will be issued as an EU-valid electronic prescription. If, for any clinical reason, a prescription cannot be issued, your consultation fee will be fully refunded.

Important Considerations Before Starting Treatment

Before commencing any GLP-1 medication, it is vital to understand that these treatments are part of a broader weight management strategy. They are most effective when combined with lifestyle interventions, including dietary changes and increased physical activity. Possible side effects, such as nausea, vomiting, diarrhea, or constipation, should be discussed with your doctor. Long-term commitment and regular follow-ups are often recommended to monitor progress and adjust treatment as needed.

How Hi-Doctor Can Help

Hi-Doctor.ai offers a streamlined, confidential pathway to an EU-licensed doctor for those considering GLP-1 medications for weight management. Our service ensures that your case is thoroughly reviewed by a qualified professional who adheres to EU medical standards. For a consultation fee of €25 every 28 days (cancel anytime) or €35 one-off, you submit a detailed medical questionnaire. An EU-licensed doctor will then assess your eligibility and clinical appropriateness for GLP-1 treatment. If the doctor determines that a prescription is suitable for your health profile, an EU-valid prescription will be issued, typically within 24 hours. This prescription can be filled at any licensed pharmacy across the 27 EU member states. In the event that a prescription is not issued, the consultation fee is fully refunded. We do not promote specific medications or guarantee a prescription. Our role is to facilitate access to professional medical assessment and, when clinically appropriate, a valid prescription from an EU-licensed doctor. This approach prioritizes your health and safety above all else.